Evommune, Inc.

EVMNNYSE • USD
28.56 USD
↗ 0.59 (2.11%)🟢LIVE (AS OF 03:29 PM EDT)
🟢Market: OPEN
Open?$27.91
High?$29.05
Low?$27.52
Prev. Close?$27.97
Volume?117.9K
Avg. Volume?N/A
VWAP?$28.25
Bid / Ask
Bid?$28.09 × 200
Ask?$28.37 × 400
Spread?$0.28
Midpoint?$28.23
Valuation & Ratios
Market Cap?988.7M
Shares Out?36.0M
Float?10.0M
Float %?31.9%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Related Companies
ZBIOANABAPGEARGXAUPHBRNSCABACLDXCLYMDBVTDNTHUPBAGMBEQFBRXGRIIFRXIMAIMUXIMVT
News
Profile
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
Employees
48
Market Cap
988.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.evommune.com
Listed
2025-11-06
Address
1841 PAGE MILL RD
PALO ALTO, CA 94304
Phone: (650) 223-7745
MarketsMoversWatchlist